Matches in SemOpenAlex for { <https://semopenalex.org/work/W2192014712> ?p ?o ?g. }
- W2192014712 endingPage "5.e9" @default.
- W2192014712 startingPage "5.e1" @default.
- W2192014712 abstract "Clear cell renal cell carcinoma (ccRCC) is well known for its hypervascularity due to the Von Hippel-Lindau/hypoxia-inducible factor dysregulation. Recent findings suggested that copper transporter 2 (CTR2) is also associated with angiogenesis through copper׳s modulation of the hypoxia-inducible factor pathway. Our group thus explored the prognostic role of CTR2 in patients with ccRCC.A total of 331 patients with ccRCC who underwent nephrectomy were enrolled between February 2005 and June 2007 at a single institution. The median follow-up was 98.97 months (2.63-120.47mo). Patients׳ samples were collected and stained for CTR2 by immunohistochemistry. The staining intensity was analyzed quantitatively and defined as high/low expression using X-tile software. Stage, Size, Grade, and Necrosis score and University of California Los Angeles Integrated Staging System score were applied to stratify patients׳ risks. Survival analyses were performed through the Kaplan-Meier method and Cox proportional hazard model. After integrating tumoral CTR2 expression with other clinical parameters, 2 nomograms were generated for overall survival (OS) and disease-free survival (DFS) prediction.CTR2 expression in ccRCC was decreased compared with that in the peritumoral tissue (P<0.001) and negatively correlated with many other clinical parameters. In survival analyses using the Kaplan-Meier method, low tumoral CTR2 expression displayed a dismal prognostic effect both in OS and DFS prediction (P<0.001). Multivariate analyses also revealed the same result after adjusted with other clinical parameters (P<0.001). Stratifying patients into 3 risk levels using the Stage, Size, Grade, and Necrosis score and University of California Los Angeles Integrated Staging System score, decreased CTR2 expression associated with shorter OS and DFS in the low- and intermediate-risk groups. Moreover, the generated nomogram integrating tumoral CTR2 expression performed better in predicting patients׳ OS than using TNM stages alone (c-index = 0.799; 95% CI: 0.752-0.846 vs. 0.691; 95% CI: 0.637-0.745).CTR2 is a novel prognostic marker for patients with ccRCC both in OS and DFS prediction, and could be incorporated with other clinical parameters for better patient risk stratification." @default.
- W2192014712 created "2016-06-24" @default.
- W2192014712 creator A5007261771 @default.
- W2192014712 creator A5015378757 @default.
- W2192014712 creator A5027284627 @default.
- W2192014712 creator A5063481044 @default.
- W2192014712 creator A5069504383 @default.
- W2192014712 creator A5076184087 @default.
- W2192014712 date "2016-01-01" @default.
- W2192014712 modified "2023-10-16" @default.
- W2192014712 title "Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma" @default.
- W2192014712 cites W1896930635 @default.
- W2192014712 cites W1967323429 @default.
- W2192014712 cites W1985213644 @default.
- W2192014712 cites W1992142098 @default.
- W2192014712 cites W1993106326 @default.
- W2192014712 cites W2010355719 @default.
- W2192014712 cites W2021279329 @default.
- W2192014712 cites W2039545078 @default.
- W2192014712 cites W2060525294 @default.
- W2192014712 cites W2069480574 @default.
- W2192014712 cites W2082331198 @default.
- W2192014712 cites W2092443043 @default.
- W2192014712 cites W2100738632 @default.
- W2192014712 cites W2109673760 @default.
- W2192014712 cites W2110841276 @default.
- W2192014712 cites W2114451783 @default.
- W2192014712 cites W2117524910 @default.
- W2192014712 cites W2125460987 @default.
- W2192014712 cites W2128222869 @default.
- W2192014712 cites W2130998543 @default.
- W2192014712 cites W2133650808 @default.
- W2192014712 cites W2138545443 @default.
- W2192014712 cites W2143768506 @default.
- W2192014712 cites W2157400322 @default.
- W2192014712 cites W2170552969 @default.
- W2192014712 doi "https://doi.org/10.1016/j.urolonc.2015.08.013" @default.
- W2192014712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26411550" @default.
- W2192014712 hasPublicationYear "2016" @default.
- W2192014712 type Work @default.
- W2192014712 sameAs 2192014712 @default.
- W2192014712 citedByCount "6" @default.
- W2192014712 countsByYear W21920147122016 @default.
- W2192014712 countsByYear W21920147122017 @default.
- W2192014712 countsByYear W21920147122020 @default.
- W2192014712 countsByYear W21920147122021 @default.
- W2192014712 countsByYear W21920147122022 @default.
- W2192014712 countsByYear W21920147122023 @default.
- W2192014712 crossrefType "journal-article" @default.
- W2192014712 hasAuthorship W2192014712A5007261771 @default.
- W2192014712 hasAuthorship W2192014712A5015378757 @default.
- W2192014712 hasAuthorship W2192014712A5027284627 @default.
- W2192014712 hasAuthorship W2192014712A5063481044 @default.
- W2192014712 hasAuthorship W2192014712A5069504383 @default.
- W2192014712 hasAuthorship W2192014712A5076184087 @default.
- W2192014712 hasConcept C10515644 @default.
- W2192014712 hasConcept C121608353 @default.
- W2192014712 hasConcept C126322002 @default.
- W2192014712 hasConcept C142724271 @default.
- W2192014712 hasConcept C143998085 @default.
- W2192014712 hasConcept C146357865 @default.
- W2192014712 hasConcept C151730666 @default.
- W2192014712 hasConcept C204232928 @default.
- W2192014712 hasConcept C207103383 @default.
- W2192014712 hasConcept C2777472916 @default.
- W2192014712 hasConcept C2780091579 @default.
- W2192014712 hasConcept C2780091936 @default.
- W2192014712 hasConcept C2780227381 @default.
- W2192014712 hasConcept C2780394083 @default.
- W2192014712 hasConcept C2781278892 @default.
- W2192014712 hasConcept C34626388 @default.
- W2192014712 hasConcept C44249647 @default.
- W2192014712 hasConcept C50382708 @default.
- W2192014712 hasConcept C71924100 @default.
- W2192014712 hasConcept C86803240 @default.
- W2192014712 hasConceptScore W2192014712C10515644 @default.
- W2192014712 hasConceptScore W2192014712C121608353 @default.
- W2192014712 hasConceptScore W2192014712C126322002 @default.
- W2192014712 hasConceptScore W2192014712C142724271 @default.
- W2192014712 hasConceptScore W2192014712C143998085 @default.
- W2192014712 hasConceptScore W2192014712C146357865 @default.
- W2192014712 hasConceptScore W2192014712C151730666 @default.
- W2192014712 hasConceptScore W2192014712C204232928 @default.
- W2192014712 hasConceptScore W2192014712C207103383 @default.
- W2192014712 hasConceptScore W2192014712C2777472916 @default.
- W2192014712 hasConceptScore W2192014712C2780091579 @default.
- W2192014712 hasConceptScore W2192014712C2780091936 @default.
- W2192014712 hasConceptScore W2192014712C2780227381 @default.
- W2192014712 hasConceptScore W2192014712C2780394083 @default.
- W2192014712 hasConceptScore W2192014712C2781278892 @default.
- W2192014712 hasConceptScore W2192014712C34626388 @default.
- W2192014712 hasConceptScore W2192014712C44249647 @default.
- W2192014712 hasConceptScore W2192014712C50382708 @default.
- W2192014712 hasConceptScore W2192014712C71924100 @default.
- W2192014712 hasConceptScore W2192014712C86803240 @default.
- W2192014712 hasFunder F4320321001 @default.
- W2192014712 hasFunder F4320321106 @default.
- W2192014712 hasFunder F4320327803 @default.